Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qilian Xiaopi Fang is a traditional Chinese medicine (TCM) formulation developed for the treatment of chronic atrophic gastritis, particularly after eradication of Helicobacter pylori infection. It is used as part of a multicenter, randomized, double-blind clinical trial in China to evaluate its efficacy and safety in this indication. The precise herbal composition and mechanism of action are not detailed in the available sources, but as with many TCM formulas, it likely contains multiple plant-based ingredients designed to restore gastrointestinal health according to TCM principles[1]. The product reflects an integration of traditional Chinese medical theory with modern clinical research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qilian Xiaopi Fang.